当前位置： SCI文献检索 > CLINICAL THERAPEUTICS期刊下所有文献 > Management of Spastic Paresis and Cervical Dystonia: Access to Therapeutic Innovations Through an International Program of Practical Courses.

Management of Spastic Paresis and Cervical Dystonia: Access to Therapeutic Innovations Through an International Program of Practical Courses.

Abstract：

PURPOSE:Our purpose was to determine satisfaction and confidence of the Ixcellence Network training program on health care practitioners using botulinum toxin A (BoNT-A) for neurologic disorders, including spastic paresis and cervical dystonia. METHODS:The Ixcellence Network training program was designed by a scientific committee of 6 experts and then tested at centers in Europe, and Latin America. The training, provided by 16 experienced neurologists and rehabilitation specialists, consisted of theoretic and practical sessions that covered the different stages of the patient's journey from diagnosis to tailored treatment and rehabilitation. Trainees' feedback and the impact on participants' practice were evaluated by 2 individual questionnaires, at the end of the session (T0) and at 6 months (T6). Trainers' feedback was also collected through an individual questionnaire. FINDINGS:Between September 2012 and December 2017, 728 trained physicians participated in training programs with 48%, 23%, and 29% of attendees participating in training sessions dedicated to adult spastic paresis, child spastic paresis, and cervical dystonia, respectively. At T0, 93% of attendees thought that they had been given new information and 90% thought that the training would change their daily practice. This was confirmed at T6 by 93% of respondents. Trainees were highly satisfied with the program, in particular with the practical sessions. Trainers expectations were met for attendees' level of expertise, motivation, language, and participation. IMPLICATIONS:In this descriptive study, we show that the Ixcellence Network program represents a new educational approach to promote consistency in care practices and dissemination of expertise on the use of BoNT-A for neurologic disorders.

journal_name

Clin Ther

journal_title

Clinical therapeutics

authors

Colosimo C,Bhidayasiri R,Fheodoroff K,Bhatia K,Chung TM,Landreau T,Jacinto LJ

doi

10.1016/j.clinthera.2019.09.007

subject

Has Abstract

pub_date

2019-11-01 00:00:00

pages

2321-2330.e4

issue

11

eissn

0149-2918

issn

1879-114X

pii

S0149-2918(19)30484-9

journal_volume

41

pub_type

杂志文章

相关文献

CLINICAL THERAPEUTICS文献大全
  • Aripiprazole: a comprehensive review of its pharmacology, clinical efficacy, and tolerability.

    abstract：BACKGROUND:Recently approved for the treatment of schizophrenia, aripiprazole represents the sixth second-generation antipsychotic (SGA) introduced to the US market. Aripiprazole is considered a partial dopaminergic agonist, acting on both postsynaptic dopamine(2) receptors and presynaptic autoreceptors, in addition to...

    journal_title：Clinical therapeutics

    pub_type： 杂志文章,评审

    doi：10.1016/s0149-2918(04)90066-5

    authors： DeLeon A,Patel NC,Crismon ML

    更新日期：2004-05-01 00:00:00

  • Acute generalized exanthematous pustulosis induced by hydroxychloroquine: three cases and a review of the literature.

    abstract：INTRODUCTION:Acute generalized exanthematous pustulosis (AGEP) is a clinical reaction pattern that is principally drug induced and is characterized by acute, extensive formation of nonfollicular sterile pustules on an erythematous and edematous substrate. Hydroxychloroquine (HHCQ), an antimalarial drug widely used to t...

    journal_title：Clinical therapeutics

    pub_type： 杂志文章,评审

    doi：10.1016/j.clinthera.2008.05.014

    authors： Paradisi A,Bugatti L,Sisto T,Filosa G,Amerio PL,Capizzi R

    更新日期：2008-05-01 00:00:00

  • Single-Center Analysis of the Potential Inappropriate Use of Intravenous Medications in Hospitalized Patients in China.

    abstract：:This study categorizes the types of inappropriate intravenous prescriptions in hospitalized patients in China. Prescription data from 2016 were retrospectively analyzed based on predefined categories of inappropriateness. Of the 123,521 patients included, 89.2% received intravenous medications, contributing to 80% of ...

    journal_title：Clinical therapeutics

    pub_type： 杂志文章

    doi：10.1016/j.clinthera.2019.05.009

    authors： Zeng S,Wang D,Yan Y,Zhu M,Liu W,Gong Z,Wang L,Sun S

    更新日期：2019-08-01 00:00:00

  • Antiemetic treatment with oral granisetron in patients receiving moderately emetogenic chemotherapy: a dose-ranging study.

    abstract：:The antiemetic efficacy and tolerability of four different oral doses of granisetron (0.25, 0.5, 1, and 2 mg twice daily [BID]) were compared in a randomized, double-blind, parallel-group, multicenter study involving 930 patients with malignant disease receiving moderately emetogenic chemotherapy over a 7- or 14-day p...

    journal_title：Clinical therapeutics

    pub_type： 临床试验,杂志文章,多中心研究,随机对照试验

    doi：10.1016/0149-2918(95)80005-0

    authors： Bleiberg HH,Spielmann M,Falkson G,Romain D

    更新日期：1995-01-01 00:00:00

  • Pharmacokinetic and pharmacodynamic properties of multiple oral doses of sitagliptin, a dipeptidyl peptidase-IV inhibitor: a double-blind, randomized, placebo-controlled study in healthy male volunteers.

    abstract：BACKGROUND:Dipeptidyl peptidase-IV (DPP-IV) inhibitors represent a new class of oral antihyperglycemic agents. Sitagliptin is an orally active and selective DPP-IV inhibitor currently in Phase III development for the treatment of type 2 diabetes mellitus. OBJECTIVE:The aim of this study was to assess the pharmacokinet...

    journal_title：Clinical therapeutics

    pub_type： 杂志文章,随机对照试验

    doi：10.1016/j.clinthera.2006.01.015

    authors： Bergman AJ,Stevens C,Zhou Y,Yi B,Laethem M,De Smet M,Snyder K,Hilliard D,Tanaka W,Zeng W,Tanen M,Wang AQ,Chen L,Winchell G,Davies MJ,Ramael S,Wagner JA,Herman GA

    更新日期：2006-01-01 00:00:00

  • Influence on hormone levels, lipid metabolism and reversibility of endocrinological changes after leuprorelin acetate depot therapy.

    abstract：:The effect of leuprorelin acetate depot on the endocrine system and on lipid metabolism was evaluated in a multicentre, noncomparative study. During the first month of treatment, suppression of serum oestradiol levels to below 20 pg/ml was achieved and luteinising hormone and follicle-stimulating hormone levels were r...

    journal_title：Clinical therapeutics

    pub_type： 临床试验,杂志文章,多中心研究

    doi：

    authors： Bühler K,Winkler U,Schindler AE

    更新日期：1992-01-01 00:00:00

  • Role of patient experience in antidepressant adherence: a retrospective data analysis.

    abstract：BACKGROUND:In a previous study, we found that past medication use was associated with medication adherence in patients prescribed atypical antipsychotics. OBJECTIVE:The present study aimed to determine whether past medication experience was associated with adherence in patients prescribed selective serotonin reuptake ...

    journal_title：Clinical therapeutics

    pub_type： 杂志文章

    doi：10.1016/j.clinthera.2008.08.014

    authors： Vanelli M,Coca-Perraillon M

    更新日期：2008-09-01 00:00:00

  • Multicenter, phase IV evaluation of intravenous ciprofloxacin as initial therapy in patients with lower respiratory tract, urinary tract, and skin/skin structure infections.

    abstract：:A prospective, open-label, multicenter, Phase IV study of the efficacy and safety of intravenous (IV) ciprofloxacin (400 mg by 60-minute infusion every 12 hours) in the treatment of lower respiratory tract infections (LRTIs), urinary tract infections (UTIs), and skin/skin structure infections (SSSIs) in hospitalized p...

    journal_title：Clinical therapeutics

    pub_type： 临床试验,杂志文章,多中心研究

    doi：10.1016/0149-2918(95)80101-4

    authors： Pankey GA

    更新日期：1995-05-01 00:00:00

  • Management patterns and outcomes of patients with venous thromboembolism in the usual community practice setting.

    abstract：OBJECTIVE:The objectives of this study were to observe a commercially insured sample diagnosed with a venous thromboembolism (VTE) event and treated postevent with warfarin and to detail the thromboembolic and bleeding outcomes in the time periods during warfarin therapy and after discontinuation of such therapy. METH...

    journal_title：Clinical therapeutics

    pub_type： 杂志文章

    doi：10.1016/s0149-2918(04)90187-7

    authors： Willey VJ,Bullano MF,Hauch O,Reynolds M,Wygant G,Hoffman L,Mayzell G,Spyropoulos AC

    更新日期：2004-07-01 00:00:00

  • Activation of kinin-prekallikrein system after infusion of factor VIII concentrates in hemophilic patients.

    abstract：:Possible changes in the kinin-prekallikrein system after infusion of factor VIII concentrate were studied in seven patients with severe hemophilia. The functional and immunological activities of factors XI and XII, prekallikrein, high molecular weight kininogen, and C-1-esterase inhibitor were measured before and at 0...

    journal_title：Clinical therapeutics

    pub_type： 杂志文章

    doi：

    authors： Alegre A,Alberca I,Vicente V

    更新日期：1986-01-01 00:00:00

  • Efficacy of budesonide in moderate to severe asthma.

    abstract：BACKGROUND:The worldwide prevalence of asthma is increasing by approximately 50% per decade. Budesonide is one of several inhaled corticosteroids available for the treatment of asthma and has been extensively evaluated in clinical trials. OBJECTIVE:This article reviews the published literature on the efficacy of budes...

    journal_title：Clinical therapeutics

    pub_type： 杂志文章,评审

    doi：10.1016/s0149-2918(02)80005-4

    authors： O'Connell EJ

    更新日期：2002-06-01 00:00:00

  • Palonosetron versus other 5-HT(3) receptor antagonists for prevention of chemotherapy-induced nausea and vomiting in patients with cancer on chemotherapy in a hospital outpatient setting.

    abstract：BACKGROUND:Despite favorable evidence from clinical trials for single-dose palonosetron versus other commercially available 5-HT(3)-receptor antagonists for the prophylaxis of chemotherapy-induced nausea and vomiting (CINV), clinical comparative data are scarce from hospital outpatient settings, where these antiemetic ...

    journal_title：Clinical therapeutics

    pub_type： 杂志文章

    doi：10.1016/j.clinthera.2011.04.009

    authors： Balu S,Buchner D,Craver C,Gayle J

    更新日期：2011-04-01 00:00:00

  • Relative effectiveness of budesonide/formoterol and fluticasone propionate/salmeterol in a 1-year, population-based, matched cohort study of patients with chronic obstructive pulmonary disease (COPD): Effect on COPD-related exacerbations, emergency depart

    abstract：BACKGROUND:According to evidence-based guidelines, the combination of inhaled corticosteroids and inhaled long-acting beta(2)-agonists in a single inhaler is recommended for patients with chronic obstructive pulmonary disease (COPD) who are experiencing exacerbations. The relative effectiveness of combination products ...

    journal_title：Clinical therapeutics

    pub_type： 杂志文章

    doi：10.1016/j.clinthera.2010.06.022

    authors： Blais L,Forget A,Ramachandran S

    更新日期：2010-07-01 00:00:00

  • Cervical cancer survivorship: long-term quality of life and social support.

    abstract：PURPOSE:Surgery, radiotherapy, and chemotherapy are the mainstays of cervical cancer treatment. Many patients receive multiple treatment modalities, each with its own long-term effects. Given the high 5-year survival rate for cervical cancer patients, evaluation and improvement of long-term quality of life are essentia...

    journal_title：Clinical therapeutics

    pub_type： 杂志文章,评审

    doi：10.1016/j.clinthera.2014.11.013

    authors： Pfaendler KS,Wenzel L,Mechanic MB,Penner KR

    更新日期：2015-01-01 00:00:00

  • Conscientious objection and abortifacient drugs.

    abstract：:The legal right to assert a conscientious objection is reviewed, using as an example the dispensing of abortifacient drugs by pharmacists. The three areas of law that most significantly concern the right to assert a conscientious refusal are employment law, conscience clauses, and religious discrimination law. Each of...

    journal_title：Clinical therapeutics

    pub_type： 杂志文章

    doi：

    authors： Brushwood DB

    更新日期：1993-01-01 00:00:00

  • Safety, Pharmacokinetics, and Pharmacodynamics of ME-401, an Oral, Potent, and Selective Inhibitor of Phosphatidylinositol 3-Kinase P110δ, Following Single Ascending Dose Administration to Healthy Volunteers.

    abstract：PURPOSE:ME-401 is a novel selective inhibitor of phosphatidylinositol 3 kinase p110δ, an enzyme often found overexpressed and overactive in B-cell malignancies. The current study was performed to assess the safety, tolerability, pharmacokinetics, and pharmacodynamics of single ascending oral doses of ME-401 in healthy ...

    journal_title：Clinical therapeutics

    pub_type： 杂志文章

    doi：10.1016/j.clinthera.2018.09.006

    authors： Moreno O,Butler T,Zann V,Willson A,Leung P,Connor A

    更新日期：2018-11-01 00:00:00

  • Results of a survey of patients with ocular allergy treated with topical ketorolac tromethamine.

    abstract：:Exposure of the eye to airborne particles in patients predisposed to allergy often results in the signs and symptoms of allergic conjunctivitis such as red, itchy eyes and ocular discharge. The mediators of these allergic symptoms include histamine, inflammatory substances such as prostaglandins, and other products of...

    journal_title：Clinical therapeutics

    pub_type： 杂志文章,多中心研究

    doi：10.1016/0149-2918(95)80066-2

    authors： Raizman MB

    更新日期：1995-09-01 00:00:00

  • A study with quinfamide in the treatment of chronic amebiasis in adults.

    abstract：:Quinfamide, a luminal amebicide, is a dichloroacetyl quinolol used to treat chronic and subacute intestinal amebiasis. Several previous dose-ranging studies have indicated that quinfamide is effective in a total dose of 300, 600, or 1,200 mg. The present study was undertaken to determine the efficacy of 100- and 200-m...

    journal_title：Clinical therapeutics

    pub_type： 杂志文章

    doi：

    authors： Guevara L,Garcia Tsao G,Uscanga LF

    更新日期：1983-01-01 00:00:00

  • Nizatidine for the treatment of pediatric gastroesophageal reflux symptoms: an open-label, multiple-dose, randomized, multicenter clinical trial in 210 children.

    abstract：BACKGROUND:Gastroesophageal reflux disease (GERD), which is reflux that produces damage or troubling symptoms, afflicts approximately 7% of infants and children to the extent that administration of physician-directed pharmacotherapy is warranted. OBJECTIVE:This study was designed in conjunction with the US Food and Dr...

    journal_title：Clinical therapeutics

    pub_type： 临床试验,杂志文章,多中心研究,随机对照试验

    doi：10.1016/j.clinthera.2005.04.008

    authors： Orenstein SR,Gremse DA,Pantaleon CD,Kling DF,Rotenberg KS

    更新日期：2005-04-01 00:00:00

  • Effects of benzothiazepine derivative (CRD-401) on blood pressure, excretion of electrolytes, and plasma renin activity.

    abstract：:A benzothiazepine derivative, CRD-401, was administered orally in a dosage of 60 to 120 mg/day to 14 patients with various renal diseases. The systolic pressure was lowered slightly in some cases after administration of CRD-401. Urine volume and urinary excretion of electrolytes were increased by the drug in most pati...

    journal_title：Clinical therapeutics

    pub_type： 杂志文章

    doi：

    authors： Funyu T,Nigawara K,Ohno K,Hamada W,Yagihashi Y

    更新日期：1981-01-01 00:00:00

  • Effect of improved disease management strategies on hospital length of stay in the treatment of congestive heart failure.

    abstract：:Congestive heart failure (CHF) afflicts more than 4.6 million people in the United States and increases at a rate of 400,000 newly diagnosed patients per year. With more than 1.5 million hospital admissions per year attributed to CHF, it is the number one cause of hospitalization. Hospital length of stay (LOS) is one ...

    journal_title：Clinical therapeutics

    pub_type： 杂志文章

    doi：10.1016/s0149-2918(96)80223-2

    authors： Simons WR,Haim M,Rizzo J,Zannad F

    更新日期：1996-07-01 00:00:00

  • New insights and treatments: opiate withdrawal and cocaine addiction.

    abstract：:Basic research in the neurosciences has led to a theory of opiate withdrawal involving endogenous opioid peptides and hyperactive norepinephrine neurons. This theory predicts the efficacy of clonidine, a nonopiate agent, in the management of opiate withdrawal. Clonidine, which offers numerous advantages over methadone...

    journal_title：Clinical therapeutics

    pub_type： 杂志文章,评审

    doi：

    authors： Gold MS,Dackis CA

    更新日期：1984-01-01 00:00:00

  • Prevalence and correlates of potentially inappropriate prescribing among ambulatory older patients in the year 2001: comparison of three explicit criteria.

    abstract：OBJECTIVES:The aims of this study were to determine the prevalence of prescribing potentially inappropriate medications (PIMs) based on the 2002 Beers criteria among ambulatory patients aged > or =65 years, to compare PIM prevalence rates based on the 1997 Beers criteria and Zhan criteria with the rate obtained using t...

    journal_title：Clinical therapeutics

    pub_type： 杂志文章

    doi：10.1016/j.clinthera.2005.01.009

    authors： Viswanathan H,Bharmal M,Thomas J 3rd

    更新日期：2005-01-01 00:00:00

  • Treatment of chronic erosive gastritis: a double-blind trial of pirenzepine and cimetidine.

    abstract：:In a double-blind study, 59 patients with chronic erosive gastritis received 50 mg of pirenzepine twice daily and 55 patients received 400 mg of cimetidine twice daily for six weeks. In both groups, days of pain, of heartburn, and of nausea per week were significantly reduced during treatment (P less than 0.01). After...

    journal_title：Clinical therapeutics

    pub_type： 临床试验,杂志文章,随机对照试验

    doi：

    authors： Dal Monte PR,D'Imperio N,Barillari A,Vezzadini P,Bensi G,Imbimbo BP

    更新日期：1989-11-01 00:00:00

  • Utilization patterns of antihypertensive drugs among the chronic kidney disease population in the United States: a cross-sectional analysis of the national health and nutrition examination survey.

    abstract：PURPOSE:Antihypertensive drugs are prescribed to patients with chronic kidney disease (CKD) for their cardioprotective and renoprotective effects. Nationally representative information on the use of antihypertensive drugs among CKD patients is limited. The purpose of this study was to assess the utilization patterns of...

    journal_title：Clinical therapeutics

    pub_type： 杂志文章

    doi：10.1016/j.clinthera.2014.11.011

    authors： Sonawane KB,Qian J,Hansen RA

    更新日期：2015-01-01 00:00:00

  • Early experiences with the stable isotope method in children.

    abstract：:A new technique to estimate water uptake by the gastrointestinal tract was tested in infants undergoing elective surgery. Patients were randomly allocated to receive either sterile water or a glucose-electrolyte solution labeled with the stable isotope H2O18. After absorption, the isotopic O18 comes to rapid equilibri...

    journal_title：Clinical therapeutics

    pub_type： 临床试验,杂志文章,随机对照试验

    doi：

    authors： Mecrow I,Miller V,Preston T

    更新日期：1990-01-01 00:00:00

  • Evaluation of health care costs and utilization patterns for patients with gout.

    abstract：BACKGROUND:The prevalence of gout has been increasing. Serum uric acid (sUA) levels ≥6 mg/dL have been associated with high morbidity and increased health care utilization. OBJECTIVE:To assess the costs and patterns of health care resource utilization for patients with gout, categorized into 3 cohorts based on sUA lev...

    journal_title：Clinical therapeutics

    pub_type： 杂志文章

    doi：10.1016/j.clinthera.2012.01.020

    authors： Park H,Rascati KL,Prasla K,McBayne T

    更新日期：2012-03-01 00:00:00

  • Economic evaluation of zuclopenthixol acetate compared with injectable haloperidol in schizophrenic patients with acute psychosis.

    abstract：:Zuclopenthixol acetate is a rapid-acting, injectable neuroleptic drug with a duration of action that allows for administration once every 2 to 3 days, in contrast to injectable haloperidol, which may require administration more than once daily. To assess the place of zuclopenthixol acetate in the treatment of acute ep...

    journal_title：Clinical therapeutics

    pub_type： 杂志文章

    doi：10.1016/s0149-2918(97)80120-8

    authors： Laurier C,Kennedy W,Lachaine J,Gariepy L,Tessier G

    更新日期：1997-03-01 00:00:00

  • Panitumumab: human monoclonal antibody against epidermal growth factor receptors for the treatment of metastatic colorectal cancer.

    abstract：BACKGROUND:Panitumumab, formerly known as ABX-EGF, was the first recombinant human immunoglobulin G2 monoclonal antibody approved by the US Food and Drug Administration for the treatment of patients with epidermal growth factor receptor-expressing metastatic colorectal cancer (mCRC) refractory to fluoropyrimidine-, oxa...

    journal_title：Clinical therapeutics

    pub_type： 杂志文章,评审

    doi：10.1016/j.clinthera.2008.01.014

    authors： Wu M,Rivkin A,Pham T

    更新日期：2008-01-01 00:00:00

  • Glycemic Control Outcomes After Canagliflozin Initiation: Observations in a Medicare and Commercial Managed Care Population in Clinical Practice.

    abstract：PURPOSE:Although the efficacy of canagliflozin has been well established in clinical trials, research regarding its use and impact on outcomes in clinical practice has been limited by the availability of data on observations up to and beyond 6 months after the initial use of canagliflozin. The purpose of this study was...

    journal_title：Clinical therapeutics

    pub_type： 杂志文章

    doi：10.1016/j.clinthera.2016.07.009

    authors： Bailey RA,Schwab P,Xu Y,Pasquale M,Renda A

    更新日期：2016-09-01 00:00:00